key: cord-1029040-986aiwvy authors: Siqueira, Thayane Santos; Souza, Edyankya Karolyne Gomes; Martins-Filho, Paulo Ricardo; Silva, José Rodrigo Santos; Gurgel, Ricardo Queiroz; MTropMed, Luis Eduardo Cuevas; Santos, Victor Santana title: Clinical characteristics and risk factors for maternal deaths due to COVID-19 in Brazil: A nationwide population-based cohort study date: 2022-01-04 journal: J Travel Med DOI: 10.1093/jtm/taab199 sha: f6570246ad7deb076096c6db6db29bdbbaa54d7a doc_id: 1029040 cord_uid: 986aiwvy BACKGROUND: Monitoring the characteristics and associated factors for death among pregnant and postpartum women with COVID-19 is necessary. We investigated the clinical characteristics and risk factors associated with maternal deaths in a nationwide cohort of Brazil. METHODS: This was a population-based cohort of all pregnant and postpartum women hospitalised with COVID-19 notified to the Sistema de Informação de Vigilância Epidemiológica da Gripe of Brazil (SIVEP-Gripe), from February 2020 to September 2021. The primary outcome was time to in-hospital death, with risks factors analysed with univariable and multivariable Cox proportional hazards regression models. RESULTS: Cumulative observation time was 248 821 person-days from hospital admission to the end of follow-up for 15 105 individuals. There were 1858 deaths (12.3%) for a maternal mortality rate of 7.5 (95% CI 7.1–7.8) per 1000 patients-days. The cumulative mortality increased over time. Black/Brown ethnicity had a higher risk of death than women self-identifying as White. Women in the North, Northeast, Central-West and Southeast regions had higher risk of death than women in the South region. The characteristics independently associated with death were a postpartum status on admission (adjusted HR 1.4 [95%CI 1.2–1.6]), pre-existing clinical conditions (adjusted HRs 1.2 [95%CI 1.1–1.3] for one and 1.3 [95%CI 1.1–1.5] for two comorbidities), hypoxemia on admission (adjusted HR 1.2 [95%CI 1.1–1.4]) and requiring non-invasive (adjusted HR 2.6 [95%CI 2.1–3.3]) or invasive ventilatory support (adjusted HR 7.1 [95%CI 5.6–9.2]). CONCLUSION: In Brazil, the in-hospital maternal mortality rate due to COVID-19 is high and the risk of death increases with the length of hospitalisation. Socio-demographic and biological factors are associated with an increased risk of maternal death. The presence of respiratory signs and symptoms should be considered as an early markers of disease severity and an adequate management is necessary. Our findings reinforce the need for vaccination of pregnant and postpartum women against COVID-19. Coronavirus disease 19 (COVID-19), an emerging infectious disease caused by the Severe Acute Respiratory Coronavirus-2 (SARS-CoV-2), became the largest public health emergency of the 21 st century. SARS-CoV-2 clinical spectrum ranges from asymptomatic to acute respiratory distress syndrome (ARDS) and death; and the worst outcomes are associated with older age, pre-existing comorbidities, 1 racial and ethnic minorities, low income, and health disparities. 2, 3 Pregnant and postpartum women experience significant physiological, hormonal and immune changes, which predispose to respiratory viral infections and severe pneumonia. 4 Although early small scale studies in high-income countries did not report worse complications from pregnant women with COVID-19, [5] [6] [7] as the pandemic progressed, it became established they also experienced adverse outcomes, such as foetal loss, preterm delivery, preeclampsia and emergency caesarean sections [8] [9] [10] [11] and intensive care unit (ICU) admission. 10,12-14 Similar to the general population, adverse outcomes are higher among women with pre-existing comorbidities 12 and in areas with marked social inequities. 15, 16 Brazilian studies have reported higher mortality rates among pregnant women with pre-existing diabetes, cardiovascular disease and obesity, 12, 13 I P T 5 neurological, haematological, or hepatic comorbidities, diabetes, chronic respiratory disorder, obesity, or immunosuppression). Data on comorbidities was dichotomised (yes/no) and categorised according to the number of pre-existing conditions (none, one, two, and ≥ three). Clinical course was reported in terms of the need for respiratory support (none, non-invasive oxygen support and invasive ventilation), admission to an intensive care unit (ICU), recovery (discharge) or death situations. The dates of hospital admission, death or discharge were also registered. The primary outcome was the time to in-hospital death. Survival time was estimated from the day of hospital admission to the day of in-hospital death. The data analysed comprised all pregnant and postpartum women aged 13 to 48 years with COVID-19 admitted to the hospital and registered in the database between epidemiological weeks 9, 2020 and 37, 2021. Complete data were not available for all variables. We did not impute missing data for ethnicity and trimester of gestation. However, missing values were interpreted as the absence of pre-existing symptoms and co-morbidities. We also interpreted missing data as non-admission to ICU. As data in SIVEP-Gripe are deidentified and publicly available, an institutional review board approval and informed consent were not required. The funder of the study had no role in study design, data collection, management, analysis, interpretation or writing of the report. A total of 2,670,106 cases of severe acute respiratory syndrome were reported to SIVEP-Gripe 8 18]; P < 0.001). A higher maternal mortality rate was found in the North region and lower rate in the South region (Supplementary Figure 2) . The univariate risk factor analysis for deaths is shown in Table admission was not associated with an increased risk of death in the multivariate analysis. Figure 2 shows the survival probability curves in the presence of these risk factors. In this nationwide population-based cohort study of hospitalised pregnant and postpartum women with laboratory-confirmed SARS-CoV-2 infection, the estimated in-hospital maternal mortality rate was 12.3% (7.5 per 1000 patient-days), with the probability of death increasing with the length of hospitalisation. The mortality rate among pregnant and postpartum women in this cohort was higher than reported from France (0.2%), 18 the United States (0.7%) 19 and the United Kingdom (1%). 20,21 Our rate is also higher than a previous study using SIVEP-Gripe data between February and December 2020, the first year of the pandemic, 22 which reported a mortality rate of 7.8%. However, the death rate reported in this cohort study was similar to that found in an earlier Brazilian study based on SIVEP-Gripe, which was carried out from February to June 2020. In that study, Takemoto et al. 23 showed that 124 out of 978 pregnant and postpartum women hospitalised in Brazil died due to complications of COVID-19, resulting in a rate of 12.7%. COVID-19 mortality rates in obstetric populations are known to vary according to the pandemic period and across countries. High-income settings with well-structured obstetric care services and sufficient supplies for maternal ICU, tend to report the lowest death rates. The distribution within countries is also heterogeneous. 24 A recent study in Brazil demonstrated that COVID-19 cases and deaths in obstetric population have heterogeneous geographical distributions, with spatial clusters with high mortality rates located in countryside and areas 10 with high socioeconomic deprivation. 24 In this cohort, the highest mortality rates were found among women hospitalised in the North (15%), the region with the lowest socioeconomic and infrastructure indicators. This North region also experienced a rapid and greater overload of cases, especially during the 2 nd wave of the pandemic, exacerbating pre-existing socioeconomic and health structure differences across the regions. 25, 26 Our findings demonstrate an increased risk of death among Black/Brown ethnicity. Racial and ethnic groups have been disproportionately affected by COVID-19, [27] [28] [29] which is a pattern previously reported by others. 12,30 Black/Brown pregnant women are also likely to have preexisting comorbidities and adverse outcomes, including preeclampsia, foetal loss and death. 31, 32 Further, Black/Brown women receive lower quality and intensity of healthcare for preventive, diagnostic and therapeutic services. [33] [34] [35] It is thus likely the pandemic synergises the deficiencies of a pre-existing obstetric healthcare and limited access to specialised health services. The mortality rate among postpartum women with COVID-19 was around 21% (12.8 per 1000 person-days), with 1.5 times higher risk of death than pregnant women. This increased risk resembles the pre-COVID-19 era, when about two-thirds of maternal deaths occurred in the postpartum period. 36 The authors declare that there is no conflict of interest. SIVEP-Gripe dataset and all other databases used in this study are publicly available. Our analysis code is available upon request to the corresponding author. This study did not receive funding. U N C O R R E C T E D M A N U S C R I P T Factors associated with mortality in patients with COVID-19. A quantitative evidence synthesis of clinical and laboratory data COVID-19 fatality rates related to social inequality in Northeast Brazil: a neighborhood-level analysis Socio-economic inequalities and COVID-19 incidence and mortality in Brazilian children: a nationwide register-based study The impact of influenza virus infection in pregnancy Maternal and perinatal outcomes with COVID-19: A systematic review of 108 pregnancies Impact of COVID-19 on maternal and neonatal outcomes: a systematic review and meta-analysis The impact of COVID-19 on pregnancy outcomes: A systematic review and meta-analysis Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: The INTERCOVID multinational cohort study COVID-19 in Amazonas, Brazil, was driven by the persistence of endemic lineages and P.1 emergence Spatiotemporal pattern of COVID-19 spread in Brazil Racial disparities in COVID-19-related deaths in brazil: Black lives matter? COVID-19 mortality among Indigenous people in Brazil: a nationwide register-based study Ethnic and regional variations in hospital mortality from COVID-19 in Brazil: a cross-sectional observational study Disproportionate impact of Coronavirus disease 2019 (COVID-19) among pregnant and postpartum Black women in Brazil through structural racism lens Mortalidade materna de mulheres negras no Brasil A cor da dor: iniquidades raciais na atenção pré-natal e ao parto no Brasil Global disparities in maternal morbidity and mortality Desigualdades raciais, sociodemográficas e na assistência ao pré-natal e ao parto Departamento de Informática do Sistema Único de Saúde (DATASUS) Maternal near miss determinants at a maternity hospital for high-risk pregnancy in northeastern Brazil: a prospective study 62 Maternal and neonatal outcomes associated with hypertensive disorders during pregnancy: Data from Maternal near miss and death among women with severe hypertensive disorders: A Brazilian multicenter surveillance study The burden of eclampsia: Results from a multicenter study on surveillance of severe maternal morbidity in Brazil COVID-19 infection: the perspectives on immune responses patients with COVID-19 in intensive care units in Lombardy, Italy Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region Factors associated with death in critically ill patients with Coronavirus disease 2019 in the US Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Early estimates of the indirect effects of the COVID-19 pandemic on maternal and child mortality in low-income and middle-income countries: a modelling study Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons